Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond

Cancer Treatment Reviews
Jean-Luc RaoulPeter R Galle

Abstract

The hepatocellular carcinoma (HCC) treatment landscape changed a decade ago, with sorafenib demonstrating survival benefit in the first-line setting and becoming the first systemic therapy to be approved for HCC. More recently, regorafenib and nivolumab have received approval in the second-line setting after sorafenib, with further positive phase 3 studies emerging in the first line (lenvatinib non-inferior to sorafenib) and second line versus placebo (cabozantinib and ramucirumab). A key recommendation in the management of patients receiving sorafenib is to promote close communication between the patient and the physician so that adverse events (AEs) are detected early and severe AEs can be prevented. Sorafenib-related AEs have been identified as clinical biomarkers for sorafenib efficacy. Healthcare professionals have become more efficient in managing AEs, identifying patients who are likely to benefit from treatment, and assessing response to treatment, resulting in a trend towards increased overall survival in the sorafenib arms of clinical studies. The rapidly changing treatment landscape due to the emergence of new treatment options (sorafenib and lenvatinib equally effective in first line; regorafenib, cabozantinib, and ...Continue Reading

Citations

Nov 20, 2018·Médecine sciences : M/S·Maud Guy, Eve-Isabelle Pécheur
Oct 31, 2018·Journal of Cancer Research and Clinical Oncology·Fabian FinkelmeierOliver Waidmann
Apr 20, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Carina HageCarola H Ries
Sep 7, 2019·Therapeutic Advances in Medical Oncology·Xiangwei HuaUlrika Warpman Berglund
Sep 24, 2019·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Ning LyuMing Zhao
Nov 11, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Xavier AdhouteMarc Bourlière
Jul 12, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Martina MeßnerJohanna Pachmayr
Aug 18, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Yu-Shui MaDa Fu
Aug 25, 2020·Journal of Gastroenterology and Hepatology·Mami HiraiHiroyuki Okada
Nov 6, 2018·World Journal of Gastroenterology : WJG·Romain DésertOrlando Musso
Sep 24, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Weiting LiaoQiu Li
Apr 16, 2020·Arquivos De Gastroenterologia·Aline Lopes ChagasThaisa de Fátima Almeida Costa
Apr 28, 2019·Nature Reviews. Gastroenterology & Hepatology·Quentin M AnsteeMathias Heikenwalder
Jul 3, 2019·JFMS Open Reports·Alexandra GuillenLaura Blackwood
May 13, 2020·Expert Review of Clinical Pharmacology·Alberto D'AngeloGiandomenico Roviello
Jan 29, 2019·BioMed Research International·C BouvryN Lepareur
Feb 16, 2019·Targeted Oncology·Emma D Deeks
Jul 18, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shuichi SetoguchiJiro Takata
May 8, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Jakob PaurBettina Grasl-Kraupp
Dec 15, 2020·Open Medicine·Jian KongWenbing Sun
Nov 3, 2020·Expert Review of Gastroenterology & Hepatology·Hui Li
Feb 20, 2021·Canadian Journal of Gastroenterology & Hepatology·Torsten DiesingerThomas Haehner
Mar 13, 2021·The Indian Journal of Medical Research·Bhawna SirohiUNKNOWN Indian Council of Medical Research Guidelines Working Group
Apr 4, 2021·Biochemical and Biophysical Research Communications·Zhibao WangFan Yao
Apr 17, 2021·Frontiers in Immunology·Raphael MohrChristoph Roderburg
May 20, 2021·Journal of Experimental & Clinical Cancer Research : CR·Xiang-Yuan LuoXing-Xing He
Jun 3, 2021·Cancers·Mar Moreno-Gonzalez, Naiara Beraza
Jul 3, 2021·Journal of Clinical Medicine·Anne Dyhl-PolkDorte Lisbet Nielsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Jordi BruixL Bolondi
Journal of Gastrointestinal Oncology
Jasmin Radhika DesaiAiwu Ruth He
© 2022 Meta ULC. All rights reserved